...
首页> 外文期刊>Clinical and Translational Allergy >Subtropical grass pollen allergens are important for allergic respiratory diseases in subtropical regions
【24h】

Subtropical grass pollen allergens are important for allergic respiratory diseases in subtropical regions

机译:亚热带草花粉过敏原对于亚热带地区的过敏性呼吸系统疾病很重要

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Grass pollen allergens are a major cause of allergic respiratory disease but traditionally prescribing practice for grass pollen allergen-specific immunotherapy has favoured pollen extracts of temperate grasses. Here we aim to compare allergy to subtropical and temperate grass pollens in patients with allergic rhinitis from a subtropical region of Australia. Methods Sensitization to pollen extracts of the subtropical Bahia grass (Paspalum notatum), Johnson grass (Sorghum halepense) and Bermuda grass (Cynodon dactylon) as well as the temperate Ryegrass (Lolium perenne) were measured by skin prick in 233 subjects from Brisbane. Grass pollen-specific IgE reactivity was tested by ELISA and cross-inhibition ELISA. Results Patients with grass pollen allergy from a subtropical region showed higher skin prick diameters with subtropical Bahia grass and Bermuda grass pollens than with Johnson grass and Ryegrass pollens. IgE reactivity was higher with pollen of Bahia grass than Bermuda grass, Johnson grass and Ryegrass. Patients showed asymmetric cross-inhibition of IgE reactivity with subtropical grass pollens that was not blocked by temperate grass pollen allergens indicating the presence of species-specific IgE binding sites of subtropical grass pollen allergens that are not represented in temperate grass pollens. Conclusions Subtropical grass pollens are more important allergen sources than temperate grass pollens for patients from a subtropical region. Targeting allergen-specific immunotherapy to subtropical grass pollen allergens in patients with allergic rhinitis in subtropical regions could improve treatment efficacy thereby reducing the burden of allergic rhinitis and asthma.
机译:背景技术草粉花粉过敏原是引起过敏性呼吸系统疾病的主要原因,但是传统上针对草粉花粉过敏原的免疫疗法的处方操作偏爱温带草的花粉提取物。在这里,我们旨在比较来自澳大利亚亚热带地区的过敏性鼻炎患者对亚热带和温带草花粉的过敏。方法通过皮肤刺刺法对来自布里斯班的233名受试者的亚热带巴伊亚草(Paspalum notatum),约翰逊草(Horghum halepense)和百慕大草(Cynodon dactylon)以及温带黑麦草(Lolium perenne)的花粉提取物进行了敏化。通过ELISA和交叉抑制ELISA测试草花粉特异性IgE反应性。结果来自亚热带地区的草花粉过敏患者的亚热带巴伊亚草和百慕大草花粉的皮肤刺直径比强生草和黑麦草花粉高。巴伊亚草的花粉的IgE反应性高于百慕大草,约翰逊草和黑麦草。患者表现出与亚热带草花粉的IgE反应性的不对称交叉抑制,但不受温带草花粉过敏原的阻断,这表明存在温带草花粉中未表现的亚热带草花粉过敏原的物种特异性IgE结合位点。结论对于亚热带地区的患者,亚热带草花粉比温带草花粉更重要的过敏原来源。针对亚热带过敏性鼻炎患者的亚热带草花粉过敏原,采用针对过敏原的特异性免疫疗法可以提高治疗效果,从而减轻过敏性鼻炎和哮喘的负担。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号